The scientist’s investigation covers issues in Breast cancer, Genome-wide association study, Genetics, Internal medicine and Estrogen receptor. Her Breast cancer research includes themes of Cancer research, Single-nucleotide polymorphism, Genotype and Bioinformatics. Her work carried out in the field of Cancer research brings together such families of science as Methylation, DNA methylation, Pathology, Ductal carcinoma and Epigenetics.
Vessela N. Kristensen has researched Genome-wide association study in several fields, including Mendelian randomization, Disease, Genetic predisposition, Chromatin and Genetic association. Her studies in Internal medicine integrate themes in fields like Endocrinology, Oncology and Exon. Her studies deal with areas such as Odds ratio, Epidemiology, Case-control study, Gynecology and Triple-negative breast cancer as well as Oncology.
Vessela N. Kristensen mainly focuses on Breast cancer, Internal medicine, Oncology, Cancer research and Genetics. Vessela N. Kristensen interconnects Genome-wide association study, Single-nucleotide polymorphism and Bioinformatics in the investigation of issues within Breast cancer. Her Genome-wide association study study combines topics in areas such as Expression quantitative trait loci, Case-control study, Endometrial cancer and Disease.
Her Oncology research incorporates themes from Prospective cohort study, Immunology, Ovarian cancer, Gynecology and Colorectal cancer. Her research in Cancer research intersects with topics in Methylation, DNA methylation, microRNA, Regulation of gene expression and Epigenetics. Her Cancer study incorporates themes from Mutation and Pathology.
Her primary scientific interests are in Breast cancer, Cancer research, Internal medicine, Oncology and Gene. Her Breast cancer study is concerned with the larger field of Cancer. Her work on Cancer prognosis as part of general Cancer study is frequently linked to Akt/PKB signaling pathway, therefore connecting diverse disciplines of science.
The concepts of her Cancer research study are interwoven with issues in Cancer cell, Immune system, microRNA and Cytokine. Her Oncology research is multidisciplinary, incorporating perspectives in Odds ratio, Proportional hazards model, Clinical trial and Prostate cancer. Her Gene study integrates concerns from other disciplines, such as Computational biology and Disease.
Vessela N. Kristensen mainly investigates Breast cancer, Internal medicine, Oncology, Computational biology and Gene. Her Breast cancer research integrates issues from Cancer research, microRNA, Metastasis and Genome-wide association study. Vessela N. Kristensen combines subjects such as CHEK2 and PALB2 with her study of Internal medicine.
Her biological study spans a wide range of topics, including Clinical trial, Treatment outcome, Randomized controlled trial, Genetic counseling and Genetic testing. Her work carried out in the field of Computational biology brings together such families of science as Gene expression profiling, Transcription factor, Expression quantitative trait loci, Genetic association and In silico. Her studies in Estrogen receptor integrate themes in fields like Bioinformatics, Germline, Medical genetics, Disease and Gene regulatory network.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Allele-specific copy number analysis of tumors
Peter Van Loo;Silje H. Nordgard;Silje H. Nordgard;Ole Christian Lingjærde;Hege G. Russnes.
Proceedings of the National Academy of Sciences of the United States of America (2010)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush.
American Journal of Human Genetics (2019)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius.
Nature Genetics (2015)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer.
Journal of the National Cancer Institute (2015)
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
Bernard Thienpont;Jessica Steinbacher;Hui Zhao;Flora D’Anna.
Nature (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Oslo University Hospital
University of Melbourne
German Cancer Research Center
Cancer Council Victoria
German Cancer Research Center
Heidelberg University
University of Copenhagen
Monash University
University of Toronto
Karolinska Institute
The RepTrak Company
University of Iowa
Arizona State University
Chinese Academy of Sciences
Newcastle University
Gaziantep University
University of Washington
Texas A&M University
Kyung Hee University
University of Delaware
Resources For The Future
Yamaguchi University
University of Alberta
Colorado School of Mines
Sapienza University of Rome
Johns Hopkins University